Ernexa Therapeutics ERNA
NASDAQ ERNA
$1.90 -0.11 (-5.47%)
As of: Nov 11, 2026 · 3:44 PM EST

Ernexa Therapeutics (ERNA) Divestments (2021)

Updated

Ernexa Therapeutics' Divestments was $119,000 in FY2021.

Analysis

Ernexa Therapeutics (ERNA) Divestments (2021) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Divestments (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - 42.00 Mn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Ernexa Therapeutics 3.31 Mn -18.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 119,000.00
API Access

Ernexa Therapeutics Divestments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=divestments&ticker=ERNA&period=max&api_key=YOUR_API_KEY